Our own meta-analysis confirmed elevated CSF neurogranin in Alzheimer’s disease and mild cognitive impairment, although other work suggests that neurogranin may not be entirely disease-specific [17,18]. Here, NRGN is linked to early-onset autosomal dominant Alzheimer disease.